Association between incident cancer and subsequent stroke

Annals of Neurology

Volumn 77, Issue 2, 2015, Pages 291-300

  Navi, Babak B ^a,b,c   Reiner, Anne S ^c   Kamel, Hooman ^a,b   Iadecola, Costantino ^a,b   Elkind, Mitchell S V ^d,e   Panageas, Katherine S ^c   DeAngelis, Lisa M ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Columbia University ^*  (United States)

^e Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; FACTUAL DATABASE; INCIDENCE; NEOPLASMS; PROSPECTIVE STUDY; REGISTER; STROKE; TRENDS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; MALE; MEDICARE; NEOPLASMS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; STROKE; UNITED STATES;

EID: 84922798260     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24325     Document Type: Article

References (34)

1. Howlader N, Noone AM, Krapcho AM, et al. SEER cancer statistics review, 1975-2011. Available at: http://seer.cancer.gov/csr/1975-2011/. Accessed July 22, 2014.
2. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.
3. Kim SG, Hong JM, Kim HY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 2010;41:798-801.
4. Navi BB, Singer S, Merkler AE, et al. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology 2014;83:26-33.
5. Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol 2010;30:311-319.
6. Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: incidence and etiology. Neurology 2004;62:2025-2030.
7. Nilsson G, Holmberg L, Garmo H, et al. Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41:423-429.
8. Chen PC, Muo CH, Lee YT, et al. Lung cancer and incidence of stroke: a population-based cohort study. Stroke 2011;42:3034-3039.
9. Tsai SJ, Huang YS, Tung CH, et al. Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study. Radiat Oncol 2013;8:41.
10. De Bruin ML, Dorresteijn LD, van't Veer MB, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009;101:928-937.
11. Chu CN, Chen SW, Bai LY, et al. Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study. Br J Cancer 2011;105:1419-1423.
12. Zoller B, Ji J, Sundquist J, Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer 2012;48:1875-1883.
13. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465-473.
14. Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol 2004;5:655-663.
15. SEER-Medicare. SEER program and data. Available at: http://appliedresearch.cancer.gov/seermedicare/aboutdata/program.html. Accessed June 17, 2014.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
18. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-1267.
19. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-1139.
20. SEER-Medicare. Calculation of comorbidity weights. Available at: http://appliedresearch.cancer.gov/seermedicare/program/comorbidity.html. Accessed July 22, 2014.
21. Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke research. Stroke 2002;33:2465-2470.
22. Lakshminarayan K, Larson JC, Virnig B, et al. Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative. Stroke 2014;45:815-821.
23. Parpia S, Julian JA, Thabane L, et al. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism. Contemp Clin Trials 2011;32:829-833.
24. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-1154.
25. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.
26. Dammacco F, Vacca A, Procaccio P, et al. Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med 2013;13:85-97.
27. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-722.
28. Uchiyama T, Matsumoto M, Kobayashi N. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy. Thromb Res 1990;59:955-965.
29. Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 1991;9:286-294.
30. Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine 1977;56:1-37.
31. Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med 1987;83:746-756.
32. Seok JM, Kim SG, Kim JW, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 2010;68:213-219.
33. Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 2010;74:494-501.
34. Birman-Deych E, Waterman AD, Yan Y, et al. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005;43:480-485.